Contribution of organ blood flow, intrinsic tissue clearance and glycaemia to the regulation of glucose use in obese and type 2 diabetic rats: A PET study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 9, 2011, Pages 726-732

  Guiducci, L ^a   Liistro, T ^a   Burchielli, S ^b   Panetta, D ^a   Bonora, D ^a   Di Cecco, P ^b   Bucci, M ^a,c   Moehrs, S ^d   Del Guerra, A ^d   Salvadori, P A ^a   Iozzo, P ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^c TURKU PET CENTRE   (Finland)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Glucose toxicity; Glucose uptake; Organperfusion; Response to acute hyperglycaemia

Indexed keywords

GLUCOSE;

ACUTE DISEASE; ANIMAL; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HYPERGLYCEMIA; LIVER; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; RAT; SKELETAL MUSCLE; ZUCKER RAT;

ACUTE DISEASE; ANIMALS; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; GLUCOSE; HYPERGLYCEMIA; LIVER; MALE; MODELS, ANIMAL; MUSCLE, SKELETAL; MYOCARDIUM; OBESITY; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, ZUCKER; REGIONAL BLOOD FLOW;

ANIMALIA; RATTUS;

EID: 80052697185     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.11.006     Document Type: Article

References (41)

1. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
2. Vigili de Kreutzenberg S., Tiengo A., Avogaro A. Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness. Nutr Metab Cardiovasc Dis 2009, 19:667-673.
3. Etgen G.J., Oldham B.A. Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. Metabolism 2000, 49:684-688.
4. Chen D., Wang M.W. Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab 2005, 7:307-317.
5. Unger R.H., Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001, 15:312-321.
6. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D et al., Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97 (2000), pp. 1784-1789.
7. Pagano C., Calcagno A., Granzotto M., Calabrese F., Thiene G., Federspil G., et al. Heart lipid accumulation in obese non-diabetic rats: effect of weight loss. Nutr Metab Cardiovasc Dis 2008, 18:189-1976.
8. Rossetti L., Giaccari A., DeFronzo R.A. Glucose toxicity. Diabetes Care 1990, 13:610-630.
9. Giaccari A., Sorice G., Muscogiuri G. Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment. Nutr Metab Cardiovasc Dis 2009, 19:365-377.
10. Bonora E., Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia 2001, 44:2107-2114.
11. Bulow J., Simonsen L., Wiggins D., Humphreys S.M., Frayn K.N., Powell D., et al. Co-ordination of hepatic and adipose tissue lipid metabolism after oral glucose. J Lipid Res 1999, 40:2034-2043.
12. Kelley D.E., Mandarino L.J. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest 1990, 86:1999-2007.
13. Jansson P.A., Larsson A., Lonnroth P.N. Relationship between blood pressure, metabolic variables and blood flow in obese subjects with or without non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1998, 28:813-818.
14. Iozzo P. Metabolic toxicity of the heart: insights from molecular imaging. Nutr Metab Cardiovasc Dis 2010, 20:147-156.
15. Del Guerra A., Bartoli A., Belcari N., Herbert D., Motta A., Vaiano A., et al. Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging. Ieee Transactions on Nuclear Science 2006, 53:1078-1083.
16. Liistro T., Guiducci L., Burchielli S., Panetta D., Belcari N., Pardini S., et al. Brain glucose overexposure and lack of acute metabolic flexibility in obesity and type 2 diabetes: a PET-[18F]FDG study in Zucker and ZDF rats. J Cereb Blood Flow Metab 2010, 30:895-899.
17. Bellina C.R., Parodi O., Camici P., Salvadori P.A., Taddei L., Fusani L., et al. Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow. J Nucl Med 1990, 31:1335-1343.
18. Chen B.C., Huang S.C., Germano G., Kuhle W., Hawkins R.A., Buxton D., et al. Noninvasive quantification of hepatic arterial blood flow with nitrogen-13-ammonia and dynamic positron emission tomography. J Nucl Med 1991, 32:2199-2206.
19. Ishizu K., Nishizawa S., Yonekura Y., Sadato N., Magata Y., Tamaki N., et al. Effects of hyperglycemia on Fdg uptake in human Brain and Glioma. J Nucl Med 1994, 35:1104-1109.
20. Yokoyama I., Inoue Y., Moritan T., Ohtomo K., Nagai R. Myocardial glucose utilisation in type II diabetes mellitus patients treated with sulphonylurea drugs. Eur J Nucl Med Mol Imaging 2006, 33:703-708.
21. Iozzo P., Jarvisalo M.J., Kiss J., Borra R., Naum G.A., Viljanen A., et al. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs. Gastroenterology 2007, 132:531-542.
22. Kelley D.E., Williams K.V., Price J.C., Goodpaster B. Determination of the lumped constant for [F-18]fluorodeoxyglucose in human skeletal muscle. J Nucl Med 1999, 40:1798-1804.
23. Virtanen K.A., Peltoniemi P., Marjamaki P., Asola M., Strindberg L., Parkkola R., et al. Human adipose tissue glucose uptake determined using [F-18]-fluoro-deoxy-glucose ([F-18]FDG and PET in combination with microdialysis. Diabetologia 2001, 44:2171-2179.
24. Kim J., Herrero P., Sharp T., Laforest R., Rowland D.J., Tai Y.C., et al. Minimally invasive method of determining blood input function from PET images in rodents. J Nucl Med 2006, 47:330-336.
25. Shoghi K.I., Welch M.J. Hybrid image and blood sampling input function for quantification of small animal dynamic PET data. Nucl Med Biol 2007, 34:989-994.
26. Welch M.J., Lewis J.S., Kim J., Sharp T.L., Dence C.S., Gropler R.J., et al. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study. J Nucl Med 2006, 47:689-697.
27. Herrero P., Kim J., Sharp T., Engelbach J.A., Lewis J.S., Gropler R.J., et al. Assessment of myocardial blood flow using 15O-Water and 1-11C-Acetate in rats with small animal PET. J Nucl Med 2006, 47:477-485.
28. Kearney M.T., Cowley A.J., Stubbs T.A., Macdonald I.A. Effect of a physiological insulin infusion on the cardiovascular responses to a high fat meal: evidence supporting a role for insulin in modulating postprandial cardiovascular homoeostasis in man. Clin Sci 1996, 91:415-423.
29. Summers L.K.M., Samra J.S., Humphreys S.M., Morris R.J., Frayn K.N. Subcutaneous abdominal adipose tissue blood flow: Variation within and between subjects and relationship to obesity. Clin Sci 1996, 91:679-683.
30. Clark M.G., Wallis M.G., Barrett E.J., Vincent M.A., Richards S.M., Clerk L.H., et al. Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol-Endocrinol Metab 2003, 284:E241-E258.
31. Knuuti M.J., Nuutila P., Ruotsalainen U., Saraste M., Harkonen R., Ahonen A., et al. Euglycemic Hyperinsulinemic Clamp and oral glucose-load in stimulating myocardial glucose-utilization during positron emission tomography. J Nucl Med 1992, 33:1255-1262.
32. Edgerton D.S., Cardin S., Neal D., Farmer B., Lautz M., Pan C., et al. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog. Am J Physiol-Endocrinol Metab 2004, 286:E510-E522.
33. Wahren J., Ekberg K. Splanchnic regulation of glucose production. Ann Rev Nutr 2007, 27:329-345.
34. Shulman G.I., Williams P.E., Liljenquist J.E., Lacy W.W., Keller U., Cherrington A.D. Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog. Metabolism 1980, 29:317-320.
35. Galante P., Mosthaf L., Kellerer M., Berti L., Tippmer S., Bossenmaier B., et al. Acute hyperglycemia Provides an insulin-independent Inducer for Glut4 Translocation in C2C12 Myotubes and rat skeletal-muscle. Diabetes 1995, 44:646-651.
36. Capaldo B., Santoro D., Riccardi G., Perrotti N., Saccá L. Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type II diabetes. J Clin Invest 1986, 77:1285-1290.
37. Vaag A., Damsbo P., Hother-Nielsen O., Beck-Nielsen H. Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35 1992, 80-88.
38. Leturque A., Brot-Laroche E., Le Gall M., Stolarczyk E., Tobin V. The role of GLUT2 in dietary sugar handling. J Physiol Biochem 2005, 61:529-537.
39. Thorens B. Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol-Gastrointestinal and Liver Physiol 1996, 33:G541-G553.
40. Shoghi K.I., Gropler R.J., Sharp T., Herrero P., Fettig N., Su Y., et al. Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation. J Nucl Med 2008, 49:1320-1327.
41. van den Brom C.E., Huisman M.C., Vlasblom R., Boontje N.M., Duijst S., Lubberink M., et al. Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol 2009, 22:8-39.